Unknown

Dataset Information

0

New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches.

ABSTRACT:

SUBMITTER: Bar-Natan M 

PROVIDER: S-EPMC6312005 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches.

Bar-Natan Michal M   Hoffman Ronald R  

Haematologica 20190101 1

Similar Datasets

Unknown Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.
| S-EPMC8945589 | biostudies-literature
Unknown Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.
| S-EPMC9818412 | biostudies-literature
Unknown Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms.
| S-EPMC7226618 | biostudies-literature
Unknown Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes.
| S-EPMC12320413 | biostudies-literature
Unknown QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms.
| S-EPMC12463673 | biostudies-literature
Unknown Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.
| S-EPMC7521397 | biostudies-literature
Unknown AKT is a therapeutic target in myeloproliferative neoplasms.
| S-EPMC4023863 | biostudies-literature
Unknown Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.
| S-EPMC8700229 | biostudies-literature
Unknown Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms.
| S-EPMC7773330 | biostudies-literature
Unknown Recent insights regarding the molecular basis of myeloproliferative neoplasms.
| S-EPMC6960053 | biostudies-literature